Suppression of postsurgical recurrence of hepatocellular carcinoma treated with autologous formalin‐fixed tumor vaccine, with special reference to glypican‐3

Publisher： John Wiley & Sons Inc

E-ISSN： 2050-0904|3|6|444-447

ISSN： 2050-0904

Source： Clinical Case Reports, Vol.3, Iss.6, 2015-06, pp. : 444-447

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recurrent peritoneal serous carcinoma that was unmanageable with paclitaxel–carboplatin therapy responded to autologous formalin‐fixed tumor vaccine

By  

Clinical Case Reports, Vol. 3, Iss. 10, 2015-10 ,pp. : 823-826

John Wiley & Sons Inc

Access to resources Recommend Favorite

Usefulness of the Novel Oncofetal Antigen Glypican-3 for Diagnosis of Hepatocellular Carcinoma and Melanoma

By Nakatsura Tetsuya   Nishimura Yasuharu  

BioDrugs, Vol. 19, Iss. 2, 2005-01 ,pp. : 71-77

Adis International

Access to resources Recommend Favorite

Serum α-fetoprotein level as a biomarker for early recurrence after R0 resection in primary hepatocellular carcinoma

By  

Family Medicine and Community Health, Vol. 1, Iss. 2, 2013-01 ,pp. : 9-14

Compuscript

Access to resources Recommend Favorite

Evaluation of hepatocellular carcinoma with portal vein tumor thrombosis by CEUS before and after hepatic arterial infusion chemotherapy

By Kirikoshi Hiroyuki   Saito Satoru   Ueno Norio   Suzuki Kaori   Takahashi Hirokazu   Yoneda Masato   Fujita Koji   Nakajima Atsushi  

Journal of Medical Ultrasonics, Vol. 37, Iss. 3, 2010-07 ,pp. : 137-141

Springer Publishing Company

Access to resources Recommend Favorite

Trends in the Treatment of Hepatocellular Carcinoma

By  

Current Drug Therapy, Vol. 5, Iss. 2, 2010-05 ,pp. : 118-121

Bentham Science Publishers

Access to resources Recommend Favorite